Trump reaches drug price deal with pharma giants, easing tariff threat
WASHINGTON, D.C.: U.S. President Donald Trump unveiled agreements with nine major pharmaceutical companies to lower the prices of medicines sold to the Medicaid program. To some cash-paying patients, a move the White House says will bring U.S. drug costs closer to those in other wealthy nations.
The companies signing the deals include Bristol Myers Squibb, Gilead Sciences, Merck, and Roche's U.S. unit Genentech,